BR112021025806A2 - Métodos para produzir um anticorpo da subclasse igg1 humana cultivando uma célula cho e uso da remoção de sítios de splice de doador não pareados em uma parte de uma sequência de ácido nucleico de humano ou hamster - Google Patents
Métodos para produzir um anticorpo da subclasse igg1 humana cultivando uma célula cho e uso da remoção de sítios de splice de doador não pareados em uma parte de uma sequência de ácido nucleico de humano ou hamsterInfo
- Publication number
- BR112021025806A2 BR112021025806A2 BR112021025806A BR112021025806A BR112021025806A2 BR 112021025806 A2 BR112021025806 A2 BR 112021025806A2 BR 112021025806 A BR112021025806 A BR 112021025806A BR 112021025806 A BR112021025806 A BR 112021025806A BR 112021025806 A2 BR112021025806 A2 BR 112021025806A2
- Authority
- BR
- Brazil
- Prior art keywords
- human
- nucleic acid
- culturing
- producing
- cho cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/60—Vectors comprising a special origin of replication system from viruses
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19183171 | 2019-06-28 | ||
| PCT/EP2020/067770 WO2020260431A1 (en) | 2019-06-28 | 2020-06-25 | Method for the production of an antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021025806A2 true BR112021025806A2 (pt) | 2022-02-08 |
Family
ID=67253661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021025806A BR112021025806A2 (pt) | 2019-06-28 | 2020-06-25 | Métodos para produzir um anticorpo da subclasse igg1 humana cultivando uma célula cho e uso da remoção de sítios de splice de doador não pareados em uma parte de uma sequência de ácido nucleico de humano ou hamster |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220220500A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3990484A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7511591B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102900433B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113993888B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020304841B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021025806A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3143803A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL289210A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021015193A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020260431A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・2・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
| AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
| US5082767A (en) | 1989-02-27 | 1992-01-21 | Hatfield G Wesley | Codon pair utilization |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| US5795737A (en) | 1994-09-19 | 1998-08-18 | The General Hospital Corporation | High level expression of proteins |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| KR100797667B1 (ko) | 1999-10-04 | 2008-01-23 | 메디카고 인코포레이티드 | 외래 유전자의 전사를 조절하는 방법 |
| JP2006238894A (ja) * | 2000-02-15 | 2006-09-14 | Amgen Inc | 線維芽細胞成長因子−23分子およびその使用 |
| ATE318908T1 (de) | 2000-05-18 | 2006-03-15 | Geneart Gmbh | Synthetische gene für gagpol und deren verwendungen |
| US7879540B1 (en) | 2000-08-24 | 2011-02-01 | Promega Corporation | Synthetic nucleic acid molecule compositions and methods of preparation |
| WO2003070957A2 (en) | 2002-02-20 | 2003-08-28 | Novozymes A/S | Plant polypeptide production |
| EP1490494A1 (en) | 2002-04-01 | 2004-12-29 | Walter Reed Army Institute of Research | Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell |
| JP5331340B2 (ja) | 2004-05-18 | 2013-10-30 | バイカル インコーポレイテッド | インフルエンザウィルスワクチン組成物、及びその使用方法 |
| EA200700751A1 (ru) * | 2004-10-05 | 2008-06-30 | Элан Фарма Интернэшнл Лимитед | Способы и композиции для улучшения продуцирования рекомбинантного белка |
| KR20090018799A (ko) | 2006-05-30 | 2009-02-23 | 다우 글로벌 테크놀로지스 인크. | 코돈 최적화 방법 |
| CA2657975A1 (en) | 2006-06-29 | 2008-01-03 | Dsm Ip Assets B.V. | A method for achieving improved polypeptide expression |
| KR101163295B1 (ko) * | 2007-06-29 | 2012-07-05 | 에프. 호프만-라 로슈 아게 | 향상된 면역글로불린을 생산하는 중쇄 돌연변이체 |
| WO2009059235A2 (en) * | 2007-11-01 | 2009-05-07 | Facet Biotech Corporation | Immunoglobulin display vectors |
| JP2012508563A (ja) * | 2008-11-12 | 2012-04-12 | シェーリング コーポレイション | 抗IGF1R発現の増強のためのβGl−IGGイントロン |
| US20100303776A1 (en) * | 2009-04-16 | 2010-12-02 | The University Of North Carolina At Chapel Hill | Methods and compositions for regulated expression of multiple nucleic acids |
| KR20130013435A (ko) | 2011-07-28 | 2013-02-06 | 차의과학대학교 산학협력단 | 태반-유래 줄기세포의 증식방법 |
| RU2612910C2 (ru) * | 2011-12-21 | 2017-03-13 | Ф. Хоффманн-Ля Рош Аг | Быстрый способ клонирования и экспрессии сегментов гена родственной вариабельной области антитела |
| CN107881196A (zh) * | 2011-12-22 | 2018-04-06 | 弗·哈夫曼-拉罗切有限公司 | 表达载体组织、新的生产用细胞产生方法及其在重组产生多肽中的用途 |
| GB2502127A (en) * | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
| JP6224077B2 (ja) * | 2012-04-17 | 2017-11-01 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 改変された核酸を用いてポリペプチドを発現させるための方法 |
| EA035266B1 (ru) * | 2014-02-28 | 2020-05-22 | Икнос Сайенсиз Са | Экспрессирующие конструкции и способы для отбора клеток-хозяев, экспрессирующих полипептиды |
| KR20180018659A (ko) * | 2015-06-08 | 2018-02-21 | 코닝 인코포레이티드 | 전달이 없는 마이크로엘이디 디스플레이 |
-
2020
- 2020-06-25 BR BR112021025806A patent/BR112021025806A2/pt unknown
- 2020-06-25 MX MX2021015193A patent/MX2021015193A/es unknown
- 2020-06-25 EP EP20734039.9A patent/EP3990484A1/en not_active Ceased
- 2020-06-25 JP JP2021577247A patent/JP7511591B2/ja active Active
- 2020-06-25 WO PCT/EP2020/067770 patent/WO2020260431A1/en not_active Ceased
- 2020-06-25 KR KR1020227002552A patent/KR102900433B1/ko active Active
- 2020-06-25 CA CA3143803A patent/CA3143803A1/en active Pending
- 2020-06-25 AU AU2020304841A patent/AU2020304841B2/en active Active
- 2020-06-25 CN CN202080045482.6A patent/CN113993888B/zh active Active
-
2021
- 2021-12-21 IL IL289210A patent/IL289210A/en unknown
- 2021-12-22 US US17/559,934 patent/US20220220500A1/en active Pending
-
2023
- 2023-09-25 JP JP2023159322A patent/JP7835713B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IL289210A (en) | 2022-02-01 |
| US20220220500A1 (en) | 2022-07-14 |
| CN113993888B (zh) | 2026-01-06 |
| AU2020304841B2 (en) | 2024-08-15 |
| MX2021015193A (es) | 2022-01-18 |
| EP3990484A1 (en) | 2022-05-04 |
| JP2023183417A (ja) | 2023-12-27 |
| KR20220024954A (ko) | 2022-03-03 |
| CA3143803A1 (en) | 2020-12-30 |
| WO2020260431A1 (en) | 2020-12-30 |
| JP7835713B2 (ja) | 2026-03-25 |
| JP2022538178A (ja) | 2022-08-31 |
| JP7511591B2 (ja) | 2024-07-05 |
| CN113993888A (zh) | 2022-01-28 |
| AU2020304841A1 (en) | 2021-12-23 |
| KR102900433B1 (ko) | 2025-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018006961A2 (pt) | composição de fortalecimento para cabelos e método para fortalecer os cabelos | |
| BR112018075688A2 (pt) | anticorpos anti-c5 e métodos de uso | |
| MX2021000934A (es) | Linfocitos t que contienen nef y métodos para producirlos. | |
| CY1123800T1 (el) | Μεθοδος για την εκτελεση ενδο-προβλεψης χρησιμοποιωντας προσαρμοζομενο φιλτρο | |
| BR112021019411A2 (pt) | Métodos para a produção de células car-nk e uso das mesmas | |
| HRP20200893T1 (hr) | Pripravci stanične kulture s antioksidansima i postupci proizvodnje polipeptida | |
| MX384138B (es) | Anticuerpos anti-c5 y métodos para su uso. | |
| BR112019011138A2 (pt) | composições e métodos relacionados com sistemas celulares para penetração em tumores sólidos | |
| NZ601743A (en) | Methods for identifying and isolating cells expressing a polypeptide | |
| PH12018501282A1 (en) | Anti-c5 antibodies and methods of use | |
| BR112021014645A2 (pt) | Método de edição de genes | |
| BR112021024946A2 (pt) | Célula de mamífero, método para produzir uma célula de mamífero implantável, e, uso de uma célula de mamífero | |
| BR112013000515A2 (pt) | método para prodduzir um composição de fator von willebrand recombinante (rvwf), sobrenadante de cultura de célula, e, composição do fator von willebrand recombinante (rvwf) | |
| MX2014010021A (es) | Anticuerpos biespecificos igg4 modificados de secuencia asimetrica. | |
| MX2021003654A (es) | Metodo para seleccionar neoepitopes. | |
| BR112015017174A2 (pt) | preparação de enxertos de nervo de tecido manipulado com matriz extracelular modificada para reparo de lesão de nervo periférico | |
| WO2019108676A8 (en) | Systems and methods of formal verification | |
| EP3943065C0 (en) | Composition of an injection formulation containing a mesenchymal stem cell hydrogel and its process of preparation, freezing and defrosting | |
| MX2021001521A (es) | Estrategias de cultivo celular para modular la glucosilacion de proteinas. | |
| BR112021020867A2 (pt) | Anticorpos, ácido nucleico, vetor, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, usos do anticorpo, método de tratamento de um indivíduo com câncer e método para reduzir a depuração | |
| BR112017018704A2 (pt) | métodos para produção de células troncos neurais e usos das mesmas | |
| BR112021020357A2 (pt) | Anticorpos anti-cd3 de alta afinidade e métodos para sua geração e uso | |
| MX2020012649A (es) | Neoantígenos especificos de tumor y métodos de uso de estos. | |
| BR112022003852A2 (pt) | Métodos de preparação de células t para terapia de células t | |
| D’Agostino et al. | Potential of biofermentative unsulfated chondroitin and hyaluronic acid in dermal repair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] |